Key result
COVID-19 pandemic linked to ~20% fewer MIs referred for invasive treatment.
Why the study?
Most reports on declining myocardial infarction incidence during COVID-19 have been anecdotal, survey-based, or geographically limited, lacking data from an open society like Sweden.
Does the COVID-19 pandemic reduce the incidence of myocardial infarction referred for coronary angiography in Sweden?
Observational (n=17,656)
Yes
Does the COVID-19 pandemic reduce the incidence of myocardial infarction referred for coronary angiography in Sweden?
Relative Risk: 0.8 (95% CI 0.74–0.86)
Absolute Event Rate: 36% vs 45%
p-value: p=<0.001
The COVID-19 pandemic was associated with a 20% reduction in the incidence of MI referred for invasive treatment in Sweden, despite the absence of a strict lockdown, with no change in short-term case fatality.
May signal missed MI events in crises; leaves open true incidence vs referral changes.
OBJECTIVE: Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited to areas with lockdowns. We examined the incidence of MI during the COVID-19 pandemic in Sweden, which has remained an open society with a different public health approach fighting COVID-19. METHODS: We assessed the incidence rate (IR) as well as the incidence rate ratios (IRRs) of all MI referred for coronary angiography in Sweden using the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR), during the COVID-19 pandemic in Sweden (1 March 2020-7 May 2020) in relation to the same days 2015-2019. RESULTS: A total of 2443 MIs were referred for coronary angiography during the COVID-19 pandemic resulting in an IR 36 MIs/day (204 MIs/100 000 per year) compared with 15 213 MIs during the reference period with an IR of 45 MIs/day (254 MIs/100 000 per year) resulting in IRR of 0.80, 95% CI (0.74 to 0.86), p<0.001. Results were consistent in all investigated patient subgroups, indicating no change in patient category seeking cardiac care. Kaplan-Meier event rates for 7-day case fatality were 439 (2.3%) compared with 37 (2.9%) (HR: 0.81, 95% CI (0.58 to 1.13), p=0.21). Time to percutaneous coronary intervention (PCI) was shorter during the pandemic and PCI was equally performed, indicating no change in quality of care during the pandemic. CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed.
No takes yet. Share an insight, caveat, or question.
Mohammad et al. (2020) conducted an observational in Myocardial infarction (n=17,656). COVID-19 pandemic vs. Same days 2015-2019 was evaluated on Incidence of myocardial infarction referred for coronary angiography (IRR 0.80, 95% CI 0.74 to 0.86, p=<0.001). The COVID-19 pandemic significantly reduced the incidence of myocardial infarction referred for invasive treatment (IRR 0.80; 95% CI 0.74 to 0.86; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: